CD33 and primary biliary cholangitis: Furthermore, PBC patients did not show any expansion in the levels of CD33+CD11b+HLA-DR−/lowCD14+ M-MDSC (HD; 3.2 ± 0.5 vs PBC; 2.4 ± 0.4, Fig. 2d).